Haemonetics Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HAZ.F | 0YX.F | ITGR | TMDX | GTN0.F | PODD | |
|---|---|---|---|---|---|---|
| Market cap | 4.69B | 6.33B | 4.30B | 2.50B | 6.40B | 10.27B |
| P/E (TTM) | 58.2 | 31.8 | 34.6 | 18.8 | 24.0 | 26.6 |
| Forward P/E | 34.3 | — | 18.4 | 32.0 | — | 19.2 |
| Price/book | 6.3 | 2.3 | 2.5 | 4.8 | 0.2 | 7.2 |
| Dividend yield | — | 2.25% | — | — | 1.91% | — |
| 1-year change | +139.63% | −9.91% | +71.28% | −44.10% | +14.00% | −54.21% |
| Today | −0.96% | −3.29% | −0.11% | −0.47% | 0.00% | +4.38% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All HAZ.F news ›Haemonetics wins approval of PerQseal Elite vascular closure system
FDA approves Haemonetics’ PerQseal Elite closure system for large-bore arterial procedures, offering rapid hemostasis and 0% major complications. Read more here. - The US FDA approved Haemonetics' (HAE) PerQseal Elite vascular closure…
Haemonetics says FDA clears vascular closure device
Oct 19 (Reuters) – Haemonetics said on Monday the US Food and Drug Administration approved its device designed to seal arterial openings created during minimally invasive heart and vascular procedures. Shares of the medical technology…
Haemonetics Corporation: Relative Strength Chart - Stock NYSE
Compare Haemonetics Corporation with the company of your choice via a Relative Strength chart. Real-time HAE price, NYSE stock exchange Relative Strength Chart Haemonetics Corporation Medical Equipment, Supplies & Distribution All…
BofA Securities Adjusts Haemonetics Price Target to $100 From $93
... Medical Equipment, Supplies & Distribution BofA Securities Adjusts Haemonetics Price Target to $100 From $93 Published on 08/12/2026 at 07:53 am EDT
Haemonetics Says CSL Plasma to Complete Rollout of Products by End-2027
Haemonetics said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027. CSL expects all of its US plasma collection... Medical Equipment, Supplies & Distribution…
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating
Haemonetics has an average rating of overweight and mean price target of $101.80, according to analysts polled by FactSet. ... Medical Equipment, Supplies & Distribution Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps…
Citigroup Upgrades Haemonetics to Buy From Neutral, Adjusts Price Target to $123 From $92
Haemonetics has an average rating of overweight and mean price target of $108.40, according to analysts polled by FactSet. ... Medical Equipment, Supplies & Distribution Citigroup Upgrades Haemonetics to Buy From Neutral, Adjusts Price…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com9
-
timothysykes.com2
-
tradingview.com2
-
cnbc.com1
-
freedom959.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.